PKD2 and cholangiocarcinoma: Furthermore, microarray analysis of cholangiocarcinoma and adjacent healthy tissues revealed differential expression of the lncRNA lnc-PKD2-2-3, which was confirmed in 60 paired samples by reverse transcription-quantitative polymerase chain reaction (RT-qPCR) [157].